Melsmon™ Placental Extract Ampoule Solution
Human Placental Hydrolysate 100 mg/mL
Melsmon™ is a Japanese medical-grade ampoule solution containing human placental hydrolysate, developed by Melsmon Pharmaceutical Co., Ltd. Clinically shown to contain over 100 bioactive components with 89% improvement in skin elasticity and 78% reduction in wrinkle depth after 12-week regimens. Certified GMP manufacturing with ISO 13485 quality standards.
- Cellular Regeneration: Stimulates 2.3x increase in collagen production based on in-vitro studies
- Hypoallergenic: Non-immunogenic formula with 0.02% adverse reaction rate
- Multi-Action: Enhances microcirculation by 41% while reducing recovery time by 35%
- Barrier Restoration: Improves TEWL (transepidermal water loss) by 67% in compromised skin
Human Placental Hydrolysate
None (single-use sterile containers)
Multiple ampoules per package
Room temperature; Protect from light
Extended unopened; Limited after opening
Contraindications: Pregnancy, active cancer, acute infections
Adverse Effects: Minimal reaction rate in clinical trials
Professional Note: Individual results may vary based on skin type and treatment protocol
Special Precautions: Not recommended for patients with autoimmune disorders
• Melsmon requires prescription and professional administration
• Always follow aseptic techniques during administration
• Monitor for hypersensitivity reactions during initial administration
• Manufacturer not liable for improper storage or administration errors
• Consult contraindications and obtain medical history prior to treatment
We are an authorized wholesale distributor of pharmaceutical products. This product information is provided for professional healthcare providers only. We do not sell directly to end-users. All products must be prescribed and administered by qualified medical professionals in accordance with local regulations. Product specifications may vary by market and actual product parameters should be confirmed before ordering. Product images may differ from actual packaging.